Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Isenberg

Showing results (41-50 of 186) with videos related to

Pageof 19
Sort By:
Clinical and Experimental Rheumatology|June 26, 2010
Exacerbation of psoriatic skin lesions in patients with psoriatic arthritis receiving anti-tumour necrosis factor-alpha therapy: description of 3 cases and review of the literatureAna Filipa Mourão, Malcolm Rustin, David Isenberg
Annals of the Rheumatic Diseases|May 4, 2019
Comment on the 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus by Fanouriakis <i>et al</i>Nathalie Costedoat-Chalumeau, David Isenberg, Michelle Petri
Arthritis Care & Research|May 17, 2012
Measures of adult systemic lupus erythematosus: updated version of British Isles Lupus Assessment Group (BILAG 2004), European Consensus Lupus Activity Measurements (ECLAM), Systemic Lupus Activity Measure, Revised (SLAM-R), Systemic Lupus Activity Questionnaire for Population Studies (SLAQ), Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI)Juanita Romero-Diaz, David Isenberg, Rosalind Ramsey-Goldman
Rheumatology (Oxford, England)|May 3, 2023
ANCA-MPO: is this a useful test?Ana Mafalda Abrantes, Lorena Montaño-Tapia, David Isenberg
Bone Marrow Transplantation|October 8, 2024
CAR-T cell therapy embarks on autoimmune diseaseAlexandros Rampotas, Johanna Richter, David Isenberg, et al.
Best Practice & Research. Clinical Rheumatology|September 10, 2005
Imaging in CNS lupusPamela L Peterson, John S Axford, David Isenberg
Seminars in Thrombosis and Hemostasis|February 15, 2017
Direct Oral Anticoagulants for Thromboprophylaxis in Patients with Antiphospholipid SyndromeHannah Cohen, Maria Efthymiou, Carolyn Gates, et al.
Rheumatology (Oxford, England)|January 9, 2023
Rituximab in myositis: where are we now? A survey of current usageTatiana Oliveira, Reşit Yıldırım, Claire Deakin, et al.
Thrombosis Research|January 23, 2021
Thrombotic antiphospholipid syndrome: A practical guide to diagnosis and managementZara Sayar, Rachel Moll, David Isenberg, et al.
Arthritis Research & Therapy|April 10, 2013
B-cell depletion in SLE: clinical and trial experience with rituximab and ocrelizumab and implications for study designVenkat Reddy, David Jayne, David Close, et al.
Pageof 19

Showing results (41-50 of 186) with videos related to

Sort By:
Pageof 19
Clinical and Experimental Rheumatology|June 26, 2010
Exacerbation of psoriatic skin lesions in patients with psoriatic arthritis receiving anti-tumour necrosis factor-alpha therapy: description of 3 cases and review of the literatureAna Filipa Mourão, Malcolm Rustin, David Isenberg
Annals of the Rheumatic Diseases|May 4, 2019
Comment on the 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus by Fanouriakis <i>et al</i>Nathalie Costedoat-Chalumeau, David Isenberg, Michelle Petri
Arthritis Care & Research|May 17, 2012
Measures of adult systemic lupus erythematosus: updated version of British Isles Lupus Assessment Group (BILAG 2004), European Consensus Lupus Activity Measurements (ECLAM), Systemic Lupus Activity Measure, Revised (SLAM-R), Systemic Lupus Activity Questionnaire for Population Studies (SLAQ), Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI)Juanita Romero-Diaz, David Isenberg, Rosalind Ramsey-Goldman
Rheumatology (Oxford, England)|May 3, 2023
ANCA-MPO: is this a useful test?Ana Mafalda Abrantes, Lorena Montaño-Tapia, David Isenberg
Bone Marrow Transplantation|October 8, 2024
CAR-T cell therapy embarks on autoimmune diseaseAlexandros Rampotas, Johanna Richter, David Isenberg, et al.
Best Practice & Research. Clinical Rheumatology|September 10, 2005
Imaging in CNS lupusPamela L Peterson, John S Axford, David Isenberg
Seminars in Thrombosis and Hemostasis|February 15, 2017
Direct Oral Anticoagulants for Thromboprophylaxis in Patients with Antiphospholipid SyndromeHannah Cohen, Maria Efthymiou, Carolyn Gates, et al.
Rheumatology (Oxford, England)|January 9, 2023
Rituximab in myositis: where are we now? A survey of current usageTatiana Oliveira, Reşit Yıldırım, Claire Deakin, et al.
Thrombosis Research|January 23, 2021
Thrombotic antiphospholipid syndrome: A practical guide to diagnosis and managementZara Sayar, Rachel Moll, David Isenberg, et al.
Arthritis Research & Therapy|April 10, 2013
B-cell depletion in SLE: clinical and trial experience with rituximab and ocrelizumab and implications for study designVenkat Reddy, David Jayne, David Close, et al.
Pageof 19